CHM 11.1% 1.0¢ chimeric therapeutics limited

change in legal team, page-4

  1. 624 Posts.
    lightbulb Created with Sketch. 4
    The case will continue as is so any matters before the court will remain as will probably the timetable. What may nonetheless happen could be an acceleration from this point - litigation funders don't exactly want to hang around especially if they like the "taste of meat on the bone". Piper Alderman as i said before appear to be more appropriate to this case so between the Litigation funder and PA one may see a bit more action.

    cheers
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.